Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$7.7 - $10.71 $10,780 - $14,994
-1,400 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$8.0 - $10.06 $8,000 - $10,060
-1,000 Reduced 41.67%
1,400 $13.5 Million
Q4 2021

Jan 14, 2022

SELL
$8.0 - $9.74 $4,000 - $4,870
-500 Reduced 17.24%
2,400 $19.2 Million
Q3 2021

Oct 12, 2021

BUY
$8.54 - $10.24 $24,765 - $29,696
2,900 New
2,900 $27,000

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $28.7M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.